Enhancement of SARS-CoV-2 N Antigen-Specific T Cell Functionality by Modulating the Autophagy-Mediated Signal Pathway in Mice
Viruses · 2023
DOI: 10.3390/v15061316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Ziyu Wen und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-Sen University, Shenzhen 518107, China. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, COVID-19. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Science and Technology Planning Project of Guangdong Province, China.
Abstract (Originalsprache)
The frequent SARS-CoV-2 variants have caused a continual challenge, weakening the effectiveness of current vaccines, and thus it is of great importance to induce robust and conserved T cellular immunity for developing the next-generation vaccine against SARS-CoV-2 variants. In this study, we proposed a conception of enhancing the SARS-CoV-2 specific T cell functionality by fusing autophagosome-associated LC3b protein to the nucleocapsid (N) (N-LC3b). When compared to N protein alone, the N-LC3b protein was more effectively targeted to the autophagosome/lysosome/MHC II compartment signal pathway and thus elicited stronger CD4+ and CD8+ T cell immune responses in mice. Importantly, the frequency of N-specific polyfunctional CD4+ and CD8+ T cells, which can simultaneously secrete multiple cytokines (IFN-γ+/IL-2+/TNF-α+), in the N-LC3b group was significantly higher than that in the N alone group. Moreover, there was a significantly improved T cell proliferation, especially for CD8+ T cells in the N-LC3b group. In addition, the N-LC3b also induced a robust humoral immune response, characterized by the Th1-biased IgG2a subclass antibodies against the SARS-CoV-2 N protein. Overall, these findings demonstrated that our strategy could effectively induce a potential SARS-CoV-2 specific T cellular immunity with enhanced magnitude, polyfunctionality, and proliferation, and thus provided insights to develop a promising strategy for the design of a novel universal vaccine against SARS-CoV-2 variants and other emerging infectious diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-Sen University, Shenzhen 518107, China.
- Nanshan District Center for Disease Control and Prevention, Shenzhen 518000, China.
- Key Laboratory of Tropical Disease Control (Sun Yat-Sen University), Ministry of Education, Guangzhou 510080, China.
ORCID-Profile: Caijun Sun
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Science and Technology Planning Project of Guangdong Province, China
- Shenzhen Science and Technology Program
- Sanming Project of Medicine in Shenzhen Nanshan
Zitieren
APA
Wen, Z., Yuan, Y., Zhao, Y., Wang, H., Han, Z., Li, M., Yuan, J., & Sun, C. (2023). Enhancement of SARS-CoV-2 N Antigen-Specific T Cell Functionality by Modulating the Autophagy-Mediated Signal Pathway in Mice. Viruses. https://doi.org/10.3390/v15061316
Vancouver
Wen Z, Yuan Y, Zhao Y, Wang H, Han Z, Li M, et al. Enhancement of SARS-CoV-2 N Antigen-Specific T Cell Functionality by Modulating the Autophagy-Mediated Signal Pathway in Mice. Viruses. 2023. doi:10.3390/v15061316
BibTeX
@article{Wen2023,
author = {Wen, Ziyu and Yuan, Yue and Zhao, Yangguo and Wang, Haohang and Han, Zirong and Li, Minchao and Yuan, Jianhui and Sun, Caijun},
title = {Enhancement of SARS-CoV-2 N Antigen-Specific T Cell Functionality by Modulating the Autophagy-Mediated Signal Pathway in Mice},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15061316}
}
EUVIMED